课题基金 / 基金详情

Development of small RNAs for HIV-1 gene and drug therapy

Development of small RNAs for HIV-1 gene and drug therapy
用于 HIV-1 基因和药物治疗的小 RNA 的开发
批准号：
345552
负责人：
Gatignol Anne
金额：
$69.62万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2021-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=345552&lang=en
关键词：
Cell Culture Combination Therapy Gene Therapy Hematopoietic Stem Cells Hiv Lentiviral Vectors Lymphocytes Ribozymes Rna Interference Viral Growth

项目摘要

项目成果

Gatignol Anne的其他基金

相似基金

相关文献

中文摘要
翻译
针对艾滋病毒感染的药物疗法能够在许多接受治疗的个人中防止艾滋病的发展。然而，他们无法消除艾滋病毒。因此，必须维持密集的药物治疗方案以延缓疾病的进展，并作为
英文摘要
Drug therapies for HIV infection are able to prevent the development of AIDS in many treated individuals. However, they are unable to eliminate the HIV virus. As a result, intensive drug regimens must be maintained to delay disease progression, and are as
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of RNA therapies against SARS-CoV-2, other coronaviruses and influenza viruses for pandemic preparedness
COVID-19 Variant Supplement - Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
HIV-induced modifications of the RNA interference pathway
海外基金